Get startedLog in
    Picture of Alligator Bioscience AB logo

    ATORX — Alligator Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Alligator Bioscience Receives EMA Orphan Designation For Mitazalimab

    Picture of Alligator Bioscience AB logoAlligator Bioscience AB
    21/08/2023 07:47
    Aug 21 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * ALLIGATOR BIOSCIENCE RECEIVES EUROPEAN MEDICINE AGENCY
ORPHAN
DESIGNATION FOR MITAZALIMAB IN PANCREATIC CANCER
    * OPTIMIZE-1 IS ON TRACK FOR TOP-LINE READOUT IN EARLY Q1
2024

Source text for Eikon:  ID:nMFN7lLzYp 
Further company coverage:  ATORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

    Recent news on Alligator Bioscience AB

    See all news